Plenco 105 Resin – 22.5%

Product Description

Plenco 105 Resin was a phenolic compound manufactured by Plenco Plastics, a specialty plastics producer that developed thermosetting resin formulations for industrial and commercial applications. Phenolic resins of this type were widely used throughout American manufacturing during much of the twentieth century, prized for their thermal stability, electrical insulating properties, mechanical strength, and resistance to chemical degradation. These characteristics made phenolic compounds essential in demanding industrial environments where conventional plastics could not perform adequately under high heat, pressure, or electrical load.

The “105” designation within Plenco’s product line identified a specific formulation developed for particular processing and performance characteristics. The “22.5%” figure associated with this product identifies the proportion of a key constituent within the compound’s composition — a specification relevant both to the material’s performance profile and, critically, to its documented asbestos content. Phenolic molding compounds of this era were frequently reinforced or filled with mineral fibers to enhance their mechanical and thermal properties, and asbestos was among the most commonly used fillers in industrial-grade formulations during the peak decades of phenolic resin production.

Plenco Plastics operated within a broader market of specialty compounders who supplied molding materials to manufacturers of electrical components, industrial equipment, automotive parts, and consumer goods. Products like Plenco 105 Resin would have been purchased in bulk by fabricating operations and processed through compression molding, transfer molding, or injection molding equipment to produce finished parts.

Asbestos Content

Litigation records document that Plenco 105 Resin contained asbestos as a component of its formulation, reflected in the 22.5% constituent designation associated with this specific product. Phenolic molding compounds were among the industrial product categories most heavily reliant on asbestos fiber as a functional filler and reinforcing agent throughout much of the mid-twentieth century. Asbestos fibers contributed to the heat resistance, dimensional stability, and structural integrity of cured phenolic parts — properties that were difficult to achieve with alternative fillers available at the time.

Plaintiffs alleged that Plenco Plastics incorporated asbestos into resin formulations such as the 105 grade without adequately warning downstream users, processors, or workers about the health hazards associated with asbestos fiber release during handling and processing. Phenolic compounds containing asbestos presented particular exposure risks because the manufacturing and molding processes involved mechanical agitation, grinding, and high-temperature curing — operations capable of releasing respirable asbestos fibers into the workplace atmosphere.

The 22.5% asbestos loading level, if representative of the fiber content by weight, would be consistent with formulations documented in other phenolic compound litigation of the same era, in which fiber contents ranging from roughly 15% to 40% were common among industrial-grade molding materials.

How Workers Were Exposed

Workers exposed to Plenco 105 Resin and similar phenolic compounds fell primarily into the broad category of industrial workers engaged in plastics processing, parts fabrication, and related manufacturing operations. Litigation records document that exposure pathways in phenolic compound manufacturing were multiple and overlapping, with the greatest risks associated with operations that disturbed the resin material in its uncured or partially cured state.

Receiving and material handling workers who unloaded, weighed, and transferred bulk resin materials were exposed during routine handling before any processing began. Phenolic molding compounds were typically supplied as granules or powder, and any agitation of these materials — including pouring, scooping, or conveying — could generate airborne dust containing asbestos fibers.

Molding press operators worked in close proximity to compression and transfer molding presses where phenolic compounds were heated and shaped under pressure. Loading the press with resin material, clearing flash or excess material from molds, and handling freshly molded parts all created opportunities for fiber release.

Finishing and machining workers faced significant exposure during post-molding operations. Cured phenolic parts frequently required trimming, deflashing, drilling, sanding, or grinding to achieve final dimensions and surface quality. Plaintiffs alleged that these dry machining operations on asbestos-containing phenolic parts generated substantial quantities of fine asbestos-laden dust that remained airborne for extended periods.

Maintenance workers and equipment technicians who serviced molding presses, conveying systems, and associated equipment were exposed through contact with accumulated resin dust and residue on machinery surfaces.

Quality control and inspection personnel who worked on the production floor in proximity to molding and finishing operations were also subject to ambient fiber exposure, even without direct hands-on contact with the resin materials.

Litigation records document that industrial facilities processing asbestos-containing phenolic compounds frequently had inadequate ventilation and dust control measures, and that respiratory protection was often unavailable or not consistently used. Workers in these environments may have carried asbestos fibers home on their clothing, creating secondary exposure risks for household members.

Diseases linked to occupational asbestos exposure — including mesothelioma, asbestosis, and asbestos-related lung cancer — typically have latency periods of twenty to fifty years between initial exposure and clinical diagnosis, meaning that individuals exposed to products like Plenco 105 Resin during peak production decades may be receiving diagnoses today.